News and Events => Opinions & Editorials => Topic started by: Natasha on July 30, 2009, 11:49:20 AM Return to Full Version
Title: European Commissioner for Human Rights Report on Gender Identity
Post by: Natasha on July 30, 2009, 11:49:20 AM
Post by: Natasha on July 30, 2009, 11:49:20 AM
European Commissioner for Human Rights Report on Gender Identity
http://aebrain.blogspot.com/2009/07/european-commissioner-for-human-rights.html (http://aebrain.blogspot.com/2009/07/european-commissioner-for-human-rights.html)
Zoe Brain
7/30/09
Whilst it is true that the a great deal of the issues faced by intersexed people overlap with trans people, the fact that they didn't specifically mention intersexed people in section 3.3 could result in continued mistreatment of adult IS people in some countries.
In France, for example, adult TS people are given a treatment path whereas adult IS people aren't (conversely, IS children are whereas TS children find it very difficult). The normal approach in France is to treat an adult IS person as a TS person and to specifically avoid any diagnosis which may point to an IS cause. If any such IS cause is discovered in any tests made, the treatment path can be withdrawn by the central authority that manages such treatments.
http://aebrain.blogspot.com/2009/07/european-commissioner-for-human-rights.html (http://aebrain.blogspot.com/2009/07/european-commissioner-for-human-rights.html)
Zoe Brain
7/30/09
Whilst it is true that the a great deal of the issues faced by intersexed people overlap with trans people, the fact that they didn't specifically mention intersexed people in section 3.3 could result in continued mistreatment of adult IS people in some countries.
In France, for example, adult TS people are given a treatment path whereas adult IS people aren't (conversely, IS children are whereas TS children find it very difficult). The normal approach in France is to treat an adult IS person as a TS person and to specifically avoid any diagnosis which may point to an IS cause. If any such IS cause is discovered in any tests made, the treatment path can be withdrawn by the central authority that manages such treatments.